Multidrug Resistance in a Urothelial Cancer Cell Line After 1-Hour Mitomycin C Exposure-Reference-Cited by-同舟云学术

Multidrug Resistance in a Urothelial Cancer Cell Line After 1-Hour Mitomycin C Exposure

Published:2009-11 Issue:5 Volume:182 Page:2472-2476
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Birare Narendrakumar¹,Lwaleed Bashir A.¹,Cooper Alan J.¹

Affiliation:

1. Department of Biomedical Sciences, University of Portsmouth, Portsmouth and Department of Urology, Southampton University Hospitals National Health Service Trust (BAL), Southampton, United Kingdom

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up;Tolley;J Urol,1996

2. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukaemia;Inaba;Cancer Res,1979

3. Establishment and characterization of a doxorubicin-resistant human bladder cancer cell line (MGH-U1R);McGovern;J Urol,1988

4. The efflux of anthracyclines in multidrugresistant cell lines;Coley;Biochem Pharmacol,1993

5. Multidrug resistance in a urothelial cancer cell line after 3, 1-hour exposures to mitomycin C;Speers;J Urol,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Regulatory Role of Nuclear Respiratory Factor 1 in Bladder Cancer Cells;Anticancer Research;2023-03-27

2. Reduction of mitomycin C resistance in human bladder cancer T24 cells by knocking-down ras oncogene;Cancer Drug Resistance;2018-03-19

3. FGF2-mediated reciprocal tumor cell-endothelial cell interplay contributes to the growth of chemoresistant cells: a potential mechanism for superficial bladder cancer recurrence;Tumor Biology;2015-10-22

4. Toll-Like Receptor 6 and Connective Tissue Growth Factor Are Significantly Upregulated in Mitomycin-C-Treated Urothelial Carcinoma Cells Under Hydrostatic Pressure Stimulation;Genetic Testing and Molecular Biomarkers;2014-06

5. Predicting Recurrence and Progression in Chinese Patients With Nonmuscle-invasive Bladder Cancer Using EORTC and CUETO Scoring Models;Urology;2013-08